Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), also known as hereditary diffuse leukoencephalopathy with spheroids, is a rare inherited neurodegenerative disorder caused by mutations in the CSF1R gene [1, 2] . ALSP is clinically characterized by cognitive, behavioral, and language impairment, movement disorders, pyramidal signs, seizures, and ataxia [3] . Brain magnetic resonance imaging (MRI) is a useful diagnostic tool that shows bilateral and predominantly frontal lobe generalized brain atrophy and white matter signal changes [4]; brain computed tomography (CT) has provided less useful information [5] . During a recent international symposium on ALSP held in Tokyo, Japan, in February 2013, Japanese researchers demonstrated the presence of brain calcification in several ALSP cases [6] .
To confirm this observation, we reviewed the available clinical charts from our collection of ALSP and identified a single familial case with brain calcification demonstrated by CT. The family was previously reported [1, 3] . The study was approved by Mayo IRB committee. The patients signed informed consent.
The patient (IV-1) developed progressive symptoms at age 47 years. She initially presented with dysarthria, loss of balance, falls, and hand tremor. On neurological examination at age 52 years, she had left-side hemiparesis. Brain CT revealed mild diffuse brain atrophy and sparse hyperdense areas in subcortical white matter of the frontal and parietal lobes (Fig. 1a-c) . Brain MRI detected extensive hyper intensity in the white matter of the right parietal lobe on T2-weighted images and fluid-attenuated inversion recovery images without contrast enhancement. At age 54 years, she experienced seizures and developed contracture in her legs. She required assistance with standing and walking. At age 54, she had predominantly left-side spasticity, hyperreflexia, and ankle clonus. Her gait was spastic. Brain CT obtained at that time revealed no significant changes (Fig. 1d-f ). She eventually developed impulsive and inappropriate behavior. Brain MRI at age 57 years demonstrated more pronounced brain atrophy. Later in the course of her illness, she was not able to speak clearly, and she died at age 58 years. The cause of death was not noted. Genetic sequencing identified the CSF1R p.G589E mutation. Her family tree is demonstrated in Fig. 1g . Clinical, pathological, and genetic characteristics of this family are summarized in Table 1 .
In the literature, we found only four reports that demonstrated brain CT of ALSP patients [5, [7] [8] [9] . However, brain calcification has not been identified radiologically and/or pathologically in any of the previously reported ALSP cases. This may be due to the punctate nature of the calcification in ALSP, as well as the decreased sensitivity of MRI in detection of calcification compared with CT. Additionally, pathological assessments were performed for only small parts of available brains, which may have prohibited identification. Some of the disorders and conditions that can manifest brain calcification can be seen in Online Resource 1. The distribution of brain calcification in our case was not identical to that typically seen in any of the disorders listed in Online Resource 1. Brain calcification was confirmed 1 year after the symptomatic disease onset, and the distribution and severity had not changed during the course of our patient's illness. This fact indicates that the calcification had potentially existed before symptomatic disease onset dependently or independently and may have been due to another underlying etiology. Calcification is thought to occur due to inflammation [10] , mineralizing microangiopathy [11] , dystrophic process [12] , abnormal metabolism of calcium [13] , superoxide production by mitochondria [14] , and To protect patient confidentiality, gender is portrayed using a diamond for all individuals except affected individuals and their spouses. A number in a square indicates a number of family members. A plus sign indicates that DNA was examined for the CSF1R sequencing analysis others; however, the mechanism of brain calcification in our case remains unknown. To confirm our result, further clinical, radiological, pathological, and biological assessment on additional ALSP cases are warranted. 
